The medication is not a crutch
Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists
These compounded products do not have the same safety, quality, and effectiveness assurances as FDA-approved drugs, and may expose patients to potentially serious health risks. Of course, the fact that compounded drugs (or any drugs) are not FDA-approved does not mean that they are necessarily unsafe
Common side effects include nausea, vomiting, diarrhea, constipation, decreased appetite, indigestion, and stomach pain
Potential risks identified in animal studies: Animal studies have shown that Semaglutide can cause adverse effects such as fetal malformations, pregnancy loss, and growth retardation
These often improve with time